Title: Drug safety in pregnancy: Assessment by FDA Safety Rating system and WHO prescribing Indicators

Authors: Arun Paul, Femy Varghese, Mariyet C.J, Nancy Varghese, Meppil Baby

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i7.91

Abstract

Objectives: To determine the safety, extent of drug use, management of diseases in pregnancy with regard to the WHO prescribing indicators and US FDA safety rating system.
Methodology: A prospective observational study was conducted in St James Hospital, Chalakudy, Thrissur by collecting inpatient’s medical data in the obstetrics and gynaecology departmentover 100 patients for a period of 6 months. Datas were collected by using “Patient data collection proforma” and results were statistically analysed by Pearson chi square test and simple graphical methods.
Results: Majority of the drugs are Category B(50.9%) and C (33.4%).The average number of drugs per prescription was 5.74 (polypharmacy) and percentage of encounters with injections and antibiotics were 76% and 44% respectively.
Conclusion: Drug use was safe and rational as per FDA safety rating and WHO prescribing indicators except for high incidence of Category C drugs, polypharmacy, and increased number of antibiotics and injection per prescription.
Keywords: Pregnancy, US FDA safety rating system, PIH ,GDM, Pregnancy trimesters, WHO indicators

References

  1. Benjamin D.M. — reducing medication errors and increasing patient safety: case studies in clinical pharmacology. J Clin Pharmacol. 43: 768–783, 2003.
  2. Christina H. Stack R.Ph. The General Use of Medicationsin Pregnancy ;Volume II, Number 8 | November/December 1999.
  3. Young VSL. Teratogenicity and Drugs in the breast milk. In: Kodakimble, MA. et al. Applied Therapeutics: The Clinical Use of Drugs 7th edition USA Lippincott Williams & Wilkins, 2001.
  4. Prasanand Sasidharan, Bhanu Prakash Kolasani, Divyashanthi An observational prospective study on prescribing pattern of drugs among pregnant women admitted in antenatal ward of a tertiary care teaching hospital in coastal town of South India. National Journal of Physiology, Pharmacy and Pharmacology. 2017 ;Vol 7( 1): 1-7.
  5. Das B, Sarkar C, Datta A, Bohra S. A study of drug use during pregnancy in a teaching hospital in western Nepal. Pharmacoep-idemiol Drug Saf. 2003;12(3):221-5.
  6. Shailesh Yadav, Garikipati Spandana Evangeline. A study on prescribing patterns of drugs in pregnant women attending a teaching hospital. International Journal of Pharmacology and Therapeutics.2016; Vol. 6(1):9-25.
  7. Jasmin Elizabeth Thomas, Elizabeth Phoeba Paul, Geethu C, Chintu S Pullan, T. Sivakumar. Assessment of Drug Use Pattern and WHO Prescribing Indicators in the Department of Obstetrics and Gynaecology Prospectively. International Journal of Pharmacy and Pharmaceutical Research. 2016; Vol. 6 (4): 378-385.
  8. Divyashree. N, A. Vikneshwari, Dr. V. J. Divya, Dr. Tapendra Bhattarai and Dr. Joga Sasidhar. Drug use pattern in inpatients of obstretics ward in a tertiary care hospital. European journal of pharmaceutical and medical research. 2016, Vol.3(11), 314-318.
  9. Bhingare P.E, Shakul M Bashir M et al. Prescription pattern in gynaecology-a reterospective study in a south Indian teaching hospital. J count med A Dent.2014;Vol.2(2):52.
  10. Shrestha P,Bhandari S.K. Pattern of drug prescribing during pregnancy in Nepalese women. Int J pharm.2013;3(4):680.

Corresponding Author

Arun Paul

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.